Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Genetics Delivers Screening Targets to Bayer


RESEARCH TRIANGLE PARK, NC--Paradigm Genetics announced that it has delivered more screening targets to Bayer in accordance with a research collaboration aimed at developing herbicides. Bayer is developing additional assays on target genes discovered in Paradigm's GeneFunction Factory.

The collaboration began in October, 1998 and reached two milestones in February when Paradigm provided the first assay and delivered release 1.1 of a customized FunctionFinder bioinformatics system.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.